Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. has announced a suspension of trading due to a planned change of control involving its major shareholders. The suspension will begin on May 25, 2026, and is expected to last no more than two trading days. The company will disclose further information as it becomes available, ensuring compliance with legal requirements. Investors are advised to pay attention to subsequent announcements and consider investment risks.
Summary generated by AI · Always verify with source document
Securities Code: 301096
Securities Abbreviation: Baicheng Pharmaceutical
Announcement Number: 2026-016
Hangzhou Baicheng Pharmaceutical Technology Co., Ltd. Announcement on Suspension of Trading Due to Planned Change of Control
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.